Sernova Corp. is a clinical stage regenerative medicine company, which engages in the development and commercialization of proprietary technologies, including Cell Pouch implantable device technologies and immune-protected therapeutic cells. The company was founded on August 19, 1998 and is headquartered in London, Canada.
^Original-Research: Sernova Corp - from First Berlin Equity Research GmbH27.09.2024 / 12:41 CET/CESTDissemination of a Research, transmitted by EQS News - a service of EQSGroup...
London, Ontario; Boston, Massachusetts, den 28. Mai 2024 - Sernova Corp. (TSX: SVA) (OTCQB: SEOVF) (FWB/XETRA: PSH), ein Biotechnologieunternehmen in der klinischen Phase,...
IRW-PRESS: Sernova Corp. : Sernova beruft Jonathan Rigby in sein Board of DirectorsLondon, Ontario; Boston, Massachusetts, den 28. Mai 2024 - Sernova Corp. (TSX: SVA) (OTCQB:...
IRW-PRESS: Sernova Corp. : Sernova gibt organisatorisches Update bekannt- Dr. Philip Toleikis geht zum 30. April 2024 in den Ruhestand- Kosteneinsparungen durch Umstrukturierung...
